The proliferation of CD4+CD25+ Treg cells can be stimulated by inhibitory cytokines, such as IL-10 and TGF-β secreted from tumor cells within the TME, and they directly inhibit the activation of CD8+ effector T cells and restrict their IL-2 production. This evidence concerns the gene TGFB1 and neoplasm.